ALLARITY THERAPEUTICS INC (ALLR:NASDAQ)

$1.73 0.045 (2.6706%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 84

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) News Sources

Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need

18-02-2026

yahoo.com

Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization

06-03-2026

yahoo.com

Allarity closes $20M financing for stenoparib advancement

07-03-2026

yahoo.com

Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress

31-03-2026

yahoo.com

Allarity Therapeutics Presents Two AACR 2026 Posters Highlighting Stenoparib’s Potential in Colorectal Cancer as well as New Predictive Data Linking DRP® and Overall Survival in Ovarian Cancer

21-04-2026

yahoo.com

Allarity Therapeutics Announces that the Stenoparib DRP® Test Has Received a Notice of Allowance from the US Patent and Trademark Office

27-04-2026

yahoo.com

Allarity Therapeutics Advances Stenoparib Toward Pivotal Development with Phase 3 Manufacturing Campaign

05-05-2026

yahoo.com

Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm

08-05-2026

yahoo.com

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

15-05-2026

yahoo.com

Are Medical Stocks Lagging Bioventus (BVS) This Year?

18-05-2026

yahoo.com

ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) Sentiment Trend

0 25 50 75 100 83 91 92 79 87 75 88 81 86 76 18-02-2026 06-03-2026 07-03-2026 31-03-2026 21-04-2026 27-04-2026 05-05-2026 08-05-2026 15-05-2026 18-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) FAQs

toggle

What is the current price of ALLARITY THERAPEUTICS INC (ALLR:NASDAQ)?

The current price of ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) is $1.73.


toggle

ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) absolute price change since previous trading day?

The absolute price change of ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) since the previous trading day is $0.045.


toggle

ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) percentage price change since previous trading day?

The percentage price change of ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) since the previous trading day is 2.6706%.


toggle

What is the most recent average sentiment score for ALLARITY THERAPEUTICS INC (ALLR:NASDAQ)?

The most recent average sentiment score for ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) is 84 out of 100.


toggle

What is the most recent average sentiment for ALLARITY THERAPEUTICS INC (ALLR:NASDAQ)?

The most recent sentiment for ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) is .


SEC-8K** Filing Available For ALLARITY THERAPEUTICS INC (ALLR:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.